ASX - Delayed Quote AUD

Trajan Group Holdings Limited (TRJ.AX)

Compare
1.0150 +0.0150 (+1.50%)
At close: 3:53 PM GMT+11
Loading Chart for TRJ.AX
DELL
  • Previous Close 1.0000
  • Open 1.0120
  • Bid 1.0000 x --
  • Ask 1.0400 x --
  • Day's Range 0.9850 - 1.0200
  • 52 Week Range 0.6750 - 1.3400
  • Volume 60,366
  • Avg. Volume 55,078
  • Market Cap (intraday) 154.544M
  • Beta (5Y Monthly) 0.68
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1700
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.40

Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, rings, inlet liners, and tubing products; pathology products, consisting of NBF containers, adhesive and frosted microscope slides, coverslips, slide storage trays/mailers, cassette storage boxes, biopsy pads, histology wax plus, microtome blades, and marking dyes and sets, and MiPlatform, a smartphone adapter. It also provides sampling products, comprising septa, caps, liners, crimping tools, well plates and sealing mats, and micro sampling tools, as well as automation systems for the analysis of biological, food, and environmental samples. The company was incorporated in 2011 and is headquartered in Ringwood, Australia.

www.trajanscimed.com

600

Full Time Employees

June 30

Fiscal Year Ends

Recent News: TRJ.AX

View More

Performance Overview: TRJ.AX

Trailing total returns as of 11/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TRJ.AX
17.81%
S&P/ASX 200 [XJO]
11.24%

1-Year Return

TRJ.AX
19.12%
S&P/ASX 200 [XJO]
20.37%

3-Year Return

TRJ.AX
68.77%
S&P/ASX 200 [XJO]
16.00%

5-Year Return

TRJ.AX
45.43%
S&P/ASX 200 [XJO]
15.96%

Compare To: TRJ.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TRJ.AX

View More

Valuation Measures

Annual
As of 11/28/2024
  • Market Cap

    154.54M

  • Enterprise Value

    199.46M

  • Trailing P/E

    --

  • Forward P/E

    144.93

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.00

  • Price/Book (mrq)

    1.50

  • Enterprise Value/Revenue

    1.29

  • Enterprise Value/EBITDA

    21.80

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -16.34%

  • Return on Assets (ttm)

    0.08%

  • Return on Equity (ttm)

    -21.80%

  • Revenue (ttm)

    155.02M

  • Net Income Avi to Common (ttm)

    -25.33M

  • Diluted EPS (ttm)

    -0.1700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.24M

  • Total Debt/Equity (mrq)

    54.61%

  • Levered Free Cash Flow (ttm)

    11.06M

Research Analysis: TRJ.AX

View More

Company Insights: TRJ.AX

Research Reports: TRJ.AX

View More

People Also Watch